Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.32 |
| ▸ | KDM4A | O75164 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29186616 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL5441155 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL38651936 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL9695892 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL38651880 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL23931188 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL6523739 | 1.00 | — | — | |
| SCHEMBL4532996 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL5654330 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C | |
| SCHEMBL28902860 | 1.00 | LMNA (0.50) | LMNATSHRALDH1A1TDP1KDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127699-A1 | One Pot Process for Preparing 'Grit-Free' Solid Cleansing Compositions | GALAXY SURFACTANTS LTD. (IN) | 2025-04-24 | — | — | US | disclosed |
| EP-4541340-A1 | A ONE POT PROCESS FOR PREPARING 'GRIT-FREE' SOLID CLEANSING COMPOSITIONS | Galaxy Surfactants Ltd. (IN) | 2025-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127699-A1 | One Pot Process for Preparing 'Grit-Free' Solid Cleansing Compositions | DEGS1, SGMS1, LIPA | LMNA 2325/4885TSHR 3444/4885ALDH1A1 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.